Novartis AG (NVS)
Last Price$109.41.9%
Market Cap$217.3B
WACC
6.8%
Cost of Equity
7.6%
Cost of Debt
0.8%
Debt to Equity
14.4%
Beta
0.9
Stock quality
7/10
Good
NVS WACC
Crunching data... Almost there!
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
NVS Cost of Equity
Crunching data... Almost there!
NVS vs Peer Set: Discount Rate Comparison
WACC
Cost of Equity
General
Discount rate
financials
Company name
Revenue growth
EPS growth
Net Income margin
Novartis AGNVS
6.8%
10.8%
(16.5%)
23.1%
Median Peer Set
7.4%
(0.6%)
3.1%
15.4%
Gilead Sciences, Inc.GILD
7.6%
(0.6%)
24.0%
20.9%
Eli Lilly and CompanyLLY
7.6%
19.6%
(15.9%)
15.4%
Merck & Co., Inc.MRK
7.6%
1.4%
(97.6%)
0.6%
Pfizer Inc.PFE
7.6%
(41.7%)
(93.2%)
3.6%
SanofiSNY
7.4%
(3.8%)
106.1%
12.6%
Johnson & JohnsonJNJ
7.0%
6.5%
102.3%
41.3%
AbbVie Inc.ABBV
6.4%
(6.4%)
(58.9%)
9.0%
Bristol-Myers Squibb CompanyBMY
5.4%
(2.5%)
30.6%
17.8%
Amgen Inc.AMGN
5.3%
7.1%
3.1%
23.8%
Explore more intrinsic value tools hub for NVS
Peter Lynch Fair Value
Margin of safety
Reverse DCF
Relative Value
DCF value calculator
Ben Graham Fair Value
Intrinsic Value
Peter Lynch charts
Earnings growth model
Earnings Power Value
FAQ
What is Novartis AG's discount rate as of Feb 21, 2025?
As of Feb 21, 2025, Novartis AG's discount rate is 6.77%. This rate is determined based on the weighted average cost of capital (WACC) and the cost of equity, factoring in Novartis AG's capital structure and risk profile.
What is Novartis AG's weighted average cost of capital (WACC)?
Novartis AG's WACC as of Feb 21, 2025, is 6.77%. This value is calculated by blending the cost of debt and cost of equity, reflecting the company’s overall cost of financing its operations.
What is Novartis AG's cost of equity?
Novartis AG's cost of equity is 7.6%, as of Feb 21, 2025. This is the return that shareholders expect based on the stock's risk level and market conditions, used to calculate the discount rate for valuing future cash flows.